Azacitidine

Azacitidine is a medication used primarily to treat certain blood cancers, such as myelodysplastic syndromes and acute myeloid leukemia. It works by modifying the activity of genes in abnormal blood cells, helping to restore normal blood cell development. Azacitidine is a type of drug called a hypomethylating agent, which interferes with the process of DNA methylation—an epigenetic change that can silence genes. By doing so, it encourages the growth of healthy blood cells and can slow or stop the progression of the disease. It is usually administered via injections and requires close medical supervision.